FDA Inspection
Elite Laboratories Inc.Elite Laboratories Inc. – FDA Inspection, Mar 13, 2020
Record Details
This FDA Inspection record concerns Elite Laboratories Inc., with an inspection on March 13, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Elite Laboratories Inc.
- Inspection Date
- March 13, 2020
- Product Type
- Drugs
View Company Profile
ID · dfdd217d-43cd-42a4-b8a7-da54742c9397
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1120647
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- Failure to comply with REMS Communication Plan
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Elite Laboratories Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2025 | Not classified | New Jersey District Office | |
| January 21, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2018 | Not classified | New Jersey District Office | |
| February 2, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Elite Laboratories Inc.
- FDA Inspection 1269549 - 2025-08-01
- FDA Inspection 1119158 - 2020-01-21
- FDA Inspection 1069135 - 2018-09-28
- FDA Inspection 1042332 - 2018-02-02
- FDA Inspection 1038658 - 2017-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.